Carmel Capital Management’s Johnson & Johnson JNJ Stock Holding History

Carmel Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,260	Closed	-$516K	–	29
2024 Q1	$516K	Sell	3,260 -15	-0.5%	-$2.39K	0.21%	27
2023 Q4	$513K	Sell	3,275 -675	-17%	-$104K	0.25%	27
2023 Q3	$615K	Hold	3,950	–	–	0.35%	28
2023 Q2	$654K	Hold	3,950	–	–	0.34%	29
2023 Q1	$612K	Hold	3,950	–	–	0.35%	30
2022 Q4	$698K	Hold	3,950	–	–	0.43%	29
2022 Q3	$645K	Hold	3,950	–	–	0.42%	30
2022 Q2	$701K	Sell	3,950 -125	-3%	-$22.3K	0.43%	30
2022 Q1	$722K	Hold	4,075	–	–	0.38%	30
2021 Q4	$697K	Buy	+4,075	New	+$667K	0.34%	31

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carmel Capital Management's JNJ Position: Q2 2024 in Review

Carmel Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 3,260 shares — an estimated $516K sold.

Carmel Capital Management first reported a position in JNJ in Q4 2021 and held it in 10 quarters. The position peaked at $722K in Q1 2022. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

Carmel Capital Management reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
Carmel Capital Management sold 3,260 Johnson & Johnson shares in Q2 2024, an estimated $516K.
Carmel Capital Management first reported a position in Johnson & Johnson in Q4 2021 and held it in 10 quarters.
Carmel Capital Management's Johnson & Johnson position peaked at $722K in Q1 2022.
3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Carmel Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.